Skip to content

SEARCH

Investing News
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Industrials
- Food & Beverage

Search

SEARCH FOR AN ARTICLE

Search

Investing News
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Industrials
- Food & Beverage

HomeNASDAQ:AEZS

NASDAQ:AEZS

Aeterna Zentaris Up Nearly 50% After Announcing FDA Approved Treatment for Adult Growth Hormone Deficiency

Aeterna Zentaris Up Nearly 50% After Announcing FDA Approved Treatment for Adult Growth Hormone Deficiency

December 21, 2017

LATEST NEWS

Investing News Burlington’s Strategic Expansion
Investing News Laptop Demand Stays Strong
Investing News HP Q4 FY2024 Earnings Report
Investing News Urban Outfitters Earnings Review
Investing News Deere Surpasses Estimates Amid Challenges

All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

Advertisers
Privacy Policy
Terms of Use
DMCA Policy
Disclaimer
Contact Us

SUBSCRIBE

To get email updates from Stock Street News.

I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

Market Jar Media Inc. © 2024